Chronic Constipation Breakthrough — New Gut Bacteria Disease Explained

Chronic constipation and gut bacteria: new constipation disease finally explained Breakthrough discovery of “bacterial constipation” links specific gut bacteria to dry stool, intestinal mucus gut health, and treatment-resistant constipation. Understand how Akkermansia muciniphila and Bacteroides thetaiotaomicron may be driving your chronic constipation—and what this means for future diagnosis and treatment. What You'll Learn: How chronic constipation can be driven by specific gut bacteria, not just diet, fluids, or motility issues. Why Akkermansia muciniphila and Bacteroides thetaiotaomicron are implicated in a new form of “bacterial constipation.” What intestinal mucus does for gut health, lubrication, and stool hydration—and what happens when it’s stripped away. How co-colonised mice developed a 2.7-fold higher colonic transit time compared to germ-free controls, and why that matters for humans. What the human data show: 71% of refractory-constipation patients carried high levels of both bacteria vs only 9% of healthy controls. Why standard constipation treatments (fiber, laxatives, stool softeners) often fail when the underlying problem is mucus-destroying bacteria. How this research could change future testing, diagnosis, and targeted therapies for chronic constipation and dry stool causes. Practical questions to ask your doctor about gut microbiome and digestion if you have treatment-resistant constipation.